Search research articles
Contact Us
Filters
Showing results (1-10 of 98) with videos related to
Page
of 10
Sort By:
Kidney International
|
October 1, 1978
Statural growth of children with renal disease
D E Potter, I Greifer
The Journal of Pharmacology and Experimental Therapeutics
|
May 1, 1975
Isoproterenol- and epinephrine-induced changes in blood glucose and tissue glycogen levels in normal and diabetic rats: the influence of alteration in endogenous insulin levels and state of nourishment
D E Potter, S Ellis
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics
|
January 1, 1996
Ocular action of an opioid peptide, DPDPE
D Wang, D E Potter
Investigative Ophthalmology & Visual Science
|
September 1, 1991
Medetomidine-induced alterations of intraocular pressure and contraction of the nictitating membrane
D E Potter, M J Ogidigben
Annals of the New York Academy of Sciences
|
July 12, 1995
Centrally mediated ocular hypotension: potential role of imidazoline receptors
W R Campbell, D E Potter
Current Eye Research
|
October 16, 2001
Central imidazoline (I(1)) receptors modulate aqueous hydrodynamics
M J Ogidigben, D E Potter
The Journal of Pharmacology and Experimental Therapeutics
|
August 16, 2001
Biphasic alterations of cAMP levels and inhibition of norepinephrine release in iris-ciliary body by bremazocine
K R Russell, D E Potter
Journal of Ocular Pharmacology
|
January 1, 1993
Comparative effects of alpha-2 and DA-2 agonists on intraocular pressure in pigmented and nonpigmented rabbits
M J Ogidigben, D E Potter
Current Eye Research
|
January 1, 1982
Effects of ergoline derivatives on intraocular pressure and iris function in rabbits and monkeys
D E Potter, J A Burke
Experimental Eye Research
|
July 12, 2001
Kappa opioid agonist-induced changes in IOP: correlation with 3H-NE release and cAMP accumulation
T T Moore, D E Potter
Page
of 10
Search research articles
Search
Showing results (1-10 of 98) with videos related to
Sort By:
Page
of 10
Kidney International
|
October 1, 1978
Statural growth of children with renal disease
D E Potter, I Greifer
The Journal of Pharmacology and Experimental Therapeutics
|
May 1, 1975
Isoproterenol- and epinephrine-induced changes in blood glucose and tissue glycogen levels in normal and diabetic rats: the influence of alteration in endogenous insulin levels and state of nourishment
D E Potter, S Ellis
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics
|
January 1, 1996
Ocular action of an opioid peptide, DPDPE
D Wang, D E Potter
Investigative Ophthalmology & Visual Science
|
September 1, 1991
Medetomidine-induced alterations of intraocular pressure and contraction of the nictitating membrane
D E Potter, M J Ogidigben
Annals of the New York Academy of Sciences
|
July 12, 1995
Centrally mediated ocular hypotension: potential role of imidazoline receptors
W R Campbell, D E Potter
Current Eye Research
|
October 16, 2001
Central imidazoline (I(1)) receptors modulate aqueous hydrodynamics
M J Ogidigben, D E Potter
The Journal of Pharmacology and Experimental Therapeutics
|
August 16, 2001
Biphasic alterations of cAMP levels and inhibition of norepinephrine release in iris-ciliary body by bremazocine
K R Russell, D E Potter
Journal of Ocular Pharmacology
|
January 1, 1993
Comparative effects of alpha-2 and DA-2 agonists on intraocular pressure in pigmented and nonpigmented rabbits
M J Ogidigben, D E Potter
Current Eye Research
|
January 1, 1982
Effects of ergoline derivatives on intraocular pressure and iris function in rabbits and monkeys
D E Potter, J A Burke
Experimental Eye Research
|
July 12, 2001
Kappa opioid agonist-induced changes in IOP: correlation with 3H-NE release and cAMP accumulation
T T Moore, D E Potter
Page
of 10